HIV Citation List: May 28 - June 10, 2010
Pubmed citations:
1. Potent In Vitro Inactivation of Both Free and Cell-Associated CCR5- and CXCR4-Tropic HIV-1 by Common Commercial Soap Bars From South Africa. Jenabian MA, Auvert B, Saïdi H, Lissouba P, Matta M, Bélec L. J Acquir Immune Defic Syndr. 2010 May 28. [Epub ahead of print]PMID: 20517160
2. Anti-HIV-1 activity of lignans from the fruits of Schisandra rubriflora. Xiao WL, Wang RR, Zhao W, Tian RR, Shang SZ, Yang LM, Yang JH, Pu JX, Zheng YT, Sun HD. Arch Pharm Res. 2010 May;33(5):697-701. Epub 2010 May 29.PMID: 20512467
3. Microvirin, a novel {alpha}(1,2)-mannose-specific lectin isolated from microcystis aeruginosa, has comparable anti-HIV-1 activity as cyanovirin-N, but a much higher safety profile. Huskens D, Ferir G, Vermeire K, Kehr JC, Balzarini J, Dittmann E, Schols D. J Biol Chem. 2010 May 27. [Epub ahead of print]PMID: 20507987
4. Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries. Chang MW, Giffin MJ, Muller R, Savage J, Lin YC, Hong S, Jin W, Whitby LR, Elder JH, Boger DL, Torbett BE. Biochem J. 2010 May 27. [Epub ahead of print]PMID: 20507280
5. Solid-Phase Synthesis of 5'-O-beta,gamma-Methylenetriphosphate Derivatives of Nucleosides and Evaluation of Their Inhibitory Activity Against HIV-1 Reverse Transcriptase. Ahmadibeni Y, Dash C, Le Grice SF, Parang K. Tetrahedron Lett. 2010 Jun 2;51(22):3010-3013.PMID: 20454539
6. The disposition and metabolism of GW695634: a non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS. de Serres M, Moss L, Sigafoos J, Sefler A, Castellino S, Bowers G, Serabjit-Singh C. Xenobiotica. 2010 Jun;40(6):437-45.PMID: 20380622
7. Anti-HIV therapy with AZT prodrugs: AZT phosphonate derivatives, current state and prospects. Khandazhinskaya A, Matyugina E, Shirokova E. Expert Opin Drug Metab Toxicol. 2010 Jun;6(6):701-14.PMID: 20380483
ISI Web of Knowledge citations:
8. Cytotoxicity of Natural Compounds Isolated from the Seeds of Garcinia afzelii. Lannang, AM; Louh, GN; Biloa, BM; Komguem, J; Mbazoa, CD; Sondengam, BL; Naesens, L; Pannecouque, C; De Clercq, E; El Ashry, EH. PLANTA MEDICA, 2010; 76(7):708-712.
9. Synthesis and In Vitro Anti-HIV Activity of Some New Schiff Base Ligands Derived from 5-Amino-4-phenyl-4H-1,2,4-triazole-3-thiol and Their Metal Complexes. Al-Masoudi, NA; Aziz, NM; Mohammed, AT. PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2009; 184(11): 2891-2901.
10. Design and Synthesis of Novel Sate Derivatives of Acyclic Isocytosine and 9-Deazaadenine C-Nucleosides. Liu, LJ; Hong, JH. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2010; 29(3): 257-266.
11. Acafusin, a Dimeric Antifungal Protein from Acacia confusa Seeds. Lam, SK; Ng, TB. PROTEIN AND PEPTIDE LETTERS, 2010; 17(7): 817-822.
12. SMALL-MOLECULE INHIBITORS OF HIV-1 REPLICATION TARGETING REVERSE TRANSCRIPTASE (RT) DIMERIZATION. Camarasa, MJ. DRUGS OF THE FUTURE, 2010; 34(SUP A): 34-35.
13. OPTIMIZATION OF A POTENT HIV-1 INTEGRASE STRAND TRANSFER INHIBITOR (INSTI): MOLECULAR MODELING, SYNTHESIS AND ANTI-HIV ACTIVITY.De Grazia, S; Ferro, S; De Luca, L; Barreca, ML; Debyser, Z; Chimirri, A. DRUGS OF THE FUTURE, 2010; 34(SUP A): 140.
14. PYRIDONE DIARYL ETHER NON-NUCLEOSIDE INHIBITORS OF HIV-1 REVERSE TRANSCRIPTASE. Kennedy-Smith, J; Arora, N; Billedeau, R; Fretland, J; Hang, JL; Heilek, G; Harris, S; Hirschfeld, D; Javanbakht, H; Li, Y; Liang, WL; Roetz, R; Smith, M; Su, GS; Suh, J; Sweeney, Z; Villasenor, A; Wu, J; Yasuda, D; Klumpp, K. DRUGS OF THE FUTURE, 2010; 34(SUP A): 150.
15. DISCOVERY OF NOVEL BICYCLIC PYRIDINE AND PYRAZINE HETEROCYCLIC SYSTEMS WITH ANTI-HIV-1 ACTIVITY. de Castro, S; Familiar, O; Balzarini, J; Camarasa, MJ; Velazquez, S. DRUGS OF THE FUTURE, 2010; 34(SUP A): 215.
16. Synthesis and anti-HIV activity evaluation of new phenyl ethyl thiourea (PET) derivatives. Ettari, R; Pinto, A; Micale, N. ARKIVOC, 2009; Part 14: 227-234.